SCHEMBL21162575

SCHEMBL21162575

CCNCNC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032043 0.75
SCHEMBL13078382 0.75 CYP2C19 (0.45)
SCHEMBL860556 0.75
SCHEMBL12744801 0.73
SCHEMBL19990 0.72
SCHEMBL6662230 0.71
SCHEMBL18757538 0.71 TP53 (0.32)
SCHEMBL13078399 0.71 CYP2C19 (0.63)
SCHEMBL14446716 0.71 CYP2C19 (0.60)
SCHEMBL15235858 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10702504-B2 Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-07-07 US disclosed
US-20190209535-A1 DEGRADATION OF TRIPARTITE MOTIF-CONTAINING PROTEIN 24 (TRIM24) BY CONJUGATION OF TRIM24 INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. 2019-07-11 US disclosed